Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Dare Bioscience Inc (NQ: DARE)
0.8301 USD  +0.0041 (+0.50%)
Streaming Delayed Price  /  Updated: 11:00 AM EDT, Jun 24, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 42,610
Open 0.8500
Bid (Size) 0.8300 (8)
Ask (Size) 0.8391 (2)
Prev. Close 0.8260
Today's Range 0.8200 - 0.8500
52wk Range 0.6000 - 3.250
Shares Outstanding 11,422,161
Dividend Yield N/A
Performance
YTD
+12.51%
+12.51%
1 Month
-4.98%
-4.98%
3 Month
-50.29%
-50.29%
6 Month
+23.90%
+23.90%
1 Year
-30.24%
-30.24%
Top News
More News
Daré Bioscience, Inc. Announces Positive Results in Thermography Feasibility Study with Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder
Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced positive findings from an investigational study designed to evaluate the feasibility of using thermography... Read More
from GlobeNewswire News Releases
Daré Bioscience to Present at the 2019 BIO International Convention
Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Johnson, President and Chief Executive Officer, will present at the 2019 BIO International... Read More
from GlobeNewswire News Releases
More News
Read More
Daré Bioscience Reports First Quarter 2019 Financial Results and Company Update
from GlobeNewswire News Releases
Daré Bioscience Announces the Publication of a Pharmacokinetics Study of DARE-FRT1, a Potential Therapy for Preterm Birth and Fertility, in Drug Delivery and Translational Research
from GlobeNewswire News Releases
Daré Bioscience to Host First Quarter 2019 Financial Results and Company Update Conference Call and Webcast
from GlobeNewswire News Releases
Dr. James Simon, Award-Winning Physician, Presents on Ovaprene® as a Promising Novel Non-Hormonal Contraceptive Method in Clinical Development
from GlobeNewswire News Releases
Health Tech Aim to Change the Way Cancer is Treated
from PR Newswire
Daré Bioscience, Inc. Prices Underwritten Public Offering of Common Stock
from GlobeNewswire News Releases
Daré Bioscience, Inc. Announces Proposed Public Offering of Common Stock
from GlobeNewswire News Releases
NetworkNewsBreaks – Daré Bioscience, Inc. (NASDAQ: DARE) Realizes $5.8M in Gross Proceeds Through Underwritten Public Offering
from NetworkNewsWire
Daré Bioscience Announces Publication of Pharmacokinetics Study of DARE-HRT1, a Potential Hormone Replacement Therapy, in the Journal of Pharmaceutical Sciences
from GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.